Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 880 of 1,261

  1. US 8404288

    Microbially-stable vitamin E solutions

    Sunny Delight Beverage Company · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  2. US 8404631

    Compositions and methods for the delivery of oxygen

    The Regents of the University of California · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  3. US 8404264

    Functionalizing implantable devices with a poly (diol citrate) polymer

    Northwestern University · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  4. US 8404244

    Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  5. US 8404300

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  6. US 8403844

    Methods for interventions

    BioMarker Pharmaceuticals, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  7. US 8404638

    Dimer VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  8. US 8404817

    Humanized anti-prostate stem cell antigen monoclonal antibody

    The Regents of the University of California · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  9. US 8404862

    Ligand-conjugated monomers

    Alnylam Pharmaceuticals, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  10. US 8404810

    Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma

    Five Prime Therapeutics, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  11. US 8404732

    Methods of treating ulcerative colitis

    LEXICON PHARMACEUTICALS, INC. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  12. US 8404806

    Isolated BRCA1 peptides and method of use

    The Regents of the University of California · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  13. US 8404849

    Processes for producing modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  14. US 8404818

    Monoclonal antibodies against orthopoxviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  15. US 8404852

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  16. US 8404869

    Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome

    MAZENCE INC. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  17. US 8404711

    5-HT4 receptor agonist compounds for treatment of cognitive disorders

    Theravance, Inc. · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  18. US 8399615

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  19. US 8399666

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  20. US 8399689

    Chrysophaentin antimicrobial compounds that inhibit FtsZ protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  21. US 8399610

    HPV vaccine comprising peptides from host cell proteins

    University College Cardiff Consultants Limited · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  22. US 8399609

    Treating or preventing extracellular matrix build-up

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  23. US 8399512

    Biocompatible biodegradable fumagillin analog conjugates

    Mersana Therapeutics, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  24. US 8399478

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.